Fig. 3
From: Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
Evaluation of the diagnostic performance of ELA level in predicting CLL
Fig. 3 | BMC Cancer
From: Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?
Evaluation of the diagnostic performance of ELA level in predicting CLL